Li, Run-Ze <br/><br/>
Identification of a new pyruvate kinase M2 isoform (PKM2) activator for the treatment of non-small-cell lung cancer (NSCLC).  [electronic resource] 

 -  Chemical biology & drug design  11 2018 
 - 1851-1858 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1747-0285 
<br/><br/><label>Standard No.: </label>10.1111/cbdd.13354  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--chemistry<br/>Apoptosis--drug effects<br/>Binding Sites<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Cell Line, Tumor<br/>Humans<br/>Isoenzymes--chemistry<br/>Lung Neoplasms--drug therapy<br/>Molecular Docking Simulation<br/>Protein Structure, Tertiary<br/>Pyruvate Kinase--chemistry<br/>Sulfonamides--chemistry